Skip to main content
. 2020 Sep 3;32:106269. doi: 10.1016/j.dib.2020.106269

Table 1.

Conditions and diseases studied in clinical trials with probiotics.

Completed studies N=826
Not yet recruiting N=139
Rank Condition N % Condition N % P
1 Digestive System Diseases 169 20,5 Communicable Diseases 26 18,7
2 Gastrointestinal Diseases 169 20,5 Infection 26 18,7
3 Communicable Diseases 164 19,9 Digestive System Diseases 21 15,1
4 Infection 164 19,9 Gastrointestinal Diseases 21 15,1
5 Digestive 110 13,3 Immune System Diseases 12 8,6
6 Intestinal Diseases 102 12,4 Mental Disorders 12 8,6 0.0009
7 Syndrome 97 11,8 Digestive 12 8,6
8 Diarrhea 74 9,0 Diarrhea 11 7,9
9 Respiratory Tract Diseases 72 8,7 Hypersensitivity 11 7,9
10 Metabolic Diseases 70 8,5 Metabolic Diseases 11 7,9
11 Gastroenteritis 65 7,9 Psychotic Disorders 11 7,9 0.0024
12 Colonic Diseases 64 7,8 Intestinal Diseases 10 7,2
13 Immune System Diseases 64 7,8 Skin Diseases 9 6,5 0.0236
14 Respiratory Tract Infections 60 7,3 Syndrome 9 6,5
15 Hypersensitivity 58 7,0 Body weight 8 5,8